Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $921,000 | $908,000 | $1,015,000 | $2,080,000 |
| Dep. & Amort. | $493,000 | $439,000 | $437,000 | $408,000 |
| Deferred Tax | $13,000 | -$49,000 | $1,000 | -$57,000 |
| Stock-Based Comp. | $88,000 | $77,000 | $77,000 | $79,000 |
| Change in WC | -$201,000 | -$145,000 | $119,000 | $87,000 |
| Other Non-Cash | $20,000 | $42,000 | $69,000 | -$364,000 |
| Operating Cash Flow | $1,334,000 | $1,272,000 | $1,718,000 | $2,233,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$425,000 | -$408,000 | -$404,000 | -$403,000 |
| Net Acquisitions | -$2,164,000 | -$611,000 | -$144,000 | $424,000 |
| Inv. Purchases | $0 | $0 | -$5,000 | -$3,000 |
| Inv. Sales/Matur. | $0 | $0 | $5,000 | $403,000 |
| Other Inv. Act. | $41,000 | -$42,000 | $5,000 | -$400,000 |
| Investing Cash Flow | -$2,548,000 | -$1,061,000 | -$543,000 | $21,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,543,000 | $748,000 | -$2,000 | -$2,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$151,000 | -$275,000 | -$1,408,000 | -$2,199,000 |
| Dividends Paid | -$331,000 | -$314,000 | -$305,000 | -$309,000 |
| Other Fin. Act. | $23,000 | $1,000 | -$17,000 | -$30,000 |
| Financing Cash Flow | $1,084,000 | $160,000 | -$1,732,000 | -$2,540,000 |
| Forex Effect | -$7,000 | $0 | $0 | $0 |
| Net Chg. in Cash | -$137,000 | $371,000 | -$557,000 | -$286,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $686,000 | $315,000 | $872,000 | $1,158,000 |
| End Cash | $549,000 | $686,000 | $315,000 | $872,000 |
| Free Cash Flow | $909,000 | $864,000 | $1,314,000 | $1,830,000 |